null

SMILES: COc1c(CC(N)=O)cc(cc1NC(=O)Nc1ccc(Oc2ccnc(NCc3ccccn3)c2)c2ccccc12)C(C)(C)C

InChI Key: InChIKey=RLIVUSXWTNLHCB-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 381081   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mitogen-activated protein kinase 14 (Homo sapiens (Human))	BDBM381081 (US9890185, Example 38(d)) Show SMILES COc1c(CC(N)=O)cc(cc1NC(=O)Nc1ccc(Oc2ccnc(NCc3ccccn3)c2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C35H36N6O4/c1-35(2,3)23-17-22(18-31(36)42)33(44-4)29(19-23)41-34(43)40-28-12-13-30(27-11-6-5-10-26(27)28)45-25-14-16-38-32(20-25)39-21-24-9-7-8-15-37-24/h5-17,19-20H,18,21H2,1-4H3,(H2,36,42)(H,38,39)(H2,40,41,43)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Cephalon					Assay Description Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...				J Med Chem 51: 5680-9 (2008) BindingDB Entry DOI: 10.7270/Q2FB558N
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 alpha (Homo sapiens (Human))	BDBM381081 (US9890185, Example 38(d)) Show SMILES COc1c(CC(N)=O)cc(cc1NC(=O)Nc1ccc(Oc2ccnc(NCc3ccccn3)c2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C35H36N6O4/c1-35(2,3)23-17-22(18-31(36)42)33(44-4)29(19-23)41-34(43)40-28-12-13-30(27-11-6-5-10-26(27)28)45-25-14-16-38-32(20-25)39-21-24-9-7-8-15-37-24/h5-17,19-20H,18,21H2,1-4H3,(H2,36,42)(H,38,39)(H2,40,41,43)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.24E+3	n/a	n/a	n/a	n/a	n/a	n/a
Cephalon					Assay Description Method 1: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining ...				J Med Chem 51: 5680-9 (2008) BindingDB Entry DOI: 10.7270/Q2FB558N
					More data for this Ligand-Target Pair
Tyrosine-protein kinase SYK (Homo sapiens (Human))	BDBM381081 (US9890185, Example 38(d)) Show SMILES COc1c(CC(N)=O)cc(cc1NC(=O)Nc1ccc(Oc2ccnc(NCc3ccccn3)c2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C35H36N6O4/c1-35(2,3)23-17-22(18-31(36)42)33(44-4)29(19-23)41-34(43)40-28-12-13-30(27-11-6-5-10-26(27)28)45-25-14-16-38-32(20-25)39-21-24-9-7-8-15-37-24/h5-17,19-20H,18,21H2,1-4H3,(H2,36,42)(H,38,39)(H2,40,41,43)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.65E+3	n/a	n/a	n/a	n/a	n/a	n/a
Cephalon					Assay Description Method 2: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to t...				J Med Chem 51: 5680-9 (2008) BindingDB Entry DOI: 10.7270/Q2FB558N
					More data for this Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src (Homo sapiens (Human))	BDBM381081 (US9890185, Example 38(d)) Show SMILES COc1c(CC(N)=O)cc(cc1NC(=O)Nc1ccc(Oc2ccnc(NCc3ccccn3)c2)c2ccccc12)C(C)(C)C Show InChI InChI=1S/C35H36N6O4/c1-35(2,3)23-17-22(18-31(36)42)33(44-4)29(19-23)41-34(43)40-28-12-13-30(27-11-6-5-10-26(27)28)45-25-14-16-38-32(20-25)39-21-24-9-7-8-15-37-24/h5-17,19-20H,18,21H2,1-4H3,(H2,36,42)(H,38,39)(H2,40,41,43)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>1.57E+3	n/a	n/a	n/a	n/a	n/a	n/a
Cephalon					Assay Description The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...				J Med Chem 51: 5680-9 (2008) BindingDB Entry DOI: 10.7270/Q2FB558N
					More data for this Ligand-Target Pair